These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6168590)

  • 1. Intraperitoneal administration of Corynebacterium parvum in patients with ascitic ovarian tumors resistant to chemotherapy: effects on cytotoxicity of tumor-associated macrophages and NK cells.
    Mantovani A; Sessa C; Peri G; Allavena P; Introna M; Polentarutti N; Mangioni C
    Int J Cancer; 1981; 27(4):437-46. PubMed ID: 6168590
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of peritoneal lymphocyte cytotoxicity in patients with ovarian cancer by intraperitoneal treatment with Corynebacterium parvum.
    Lichtenstein A; Berek J; Bast R; Spina C; Hacker N; Knapp RC; Zighelboim J
    J Biol Response Mod; 1984 Aug; 3(4):371-8. PubMed ID: 6541243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Corynebacterium parvum after intraperitoneal injection in hamsters.
    Duthu A; Alexandrov I; Le Goffic N; De Vaux St Cyr C
    Dev Comp Immunol; 1984; 8(1):231-6. PubMed ID: 6233193
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of natural killer activity by tumor-associated lymphoid cells from ascites ovarian carcinomas.
    Allavena P; Introna M; Mangioni C; Mantovani A
    J Natl Cancer Inst; 1981 Aug; 67(2):319-25. PubMed ID: 6943371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic control of a retrovirus-associated murine adenocarcinoma. VIII. Corynebacterium parvum-activated natural killer cells as potent antibody-dependent cell-mediated cytotoxicity effectors.
    Weinhold KJ; Bolognesi DP; Matthews TJ
    J Natl Cancer Inst; 1985 Oct; 75(4):717-24. PubMed ID: 3862904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity on tumor cells of peripheral blood monocytes and tumor-associated macrophages in patients with ascites ovarian tumors.
    Mantovani A; Polentarutti N; Peri G; Shavit ZB; Vecchi A; Bolis G; Mangioni C
    J Natl Cancer Inst; 1980 Jun; 64(6):1307-15. PubMed ID: 6246299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer inhibitory substance produced by the peritoneal cells of patients with ovarian cancer.
    Lichtenstein AK; Berek J; Zighelboim J
    J Natl Cancer Inst; 1985 Feb; 74(2):349-55. PubMed ID: 3856049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model.
    Geller MA; Knorr DA; Hermanson DA; Pribyl L; Bendzick L; McCullar V; Miller JS; Kaufman DS
    Cytotherapy; 2013 Oct; 15(10):1297-306. PubMed ID: 23993303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer activity of lymphoid cells isolated from human ascitic ovarian tumors.
    Mantovani A; Allavena P; Sessa C; Bolis G; Mangioni C
    Int J Cancer; 1980 May; 25(5):573-82. PubMed ID: 6154662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid tumor-derived target cell susceptibility to macrophages and natural killer/natural cytotoxic cells in the rat.
    Zöller M; Matzku S
    Immunobiology; 1983 May; 164(5):349-60. PubMed ID: 6603412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal immunotherapy of epithelial ovarian carcinoma with Corynebacterium parvum.
    Berek JS; Knapp RC; Hacker NF; Lichtenstein A; Jung T; Spina C; Obrist R; Griffiths CT; Berkowitz RS; Parker L
    Am J Obstet Gynecol; 1985 Aug; 152(8):1003-10. PubMed ID: 2992276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of advanced ovarian malignancy with chemoimmunotherapy using autologous tumor and Corynebacterium parvum.
    Gusdon JP; Homesley HD; Jobson VW; Muss HB
    Obstet Gynecol; 1983 Dec; 62(6):728-35. PubMed ID: 6633998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural immunity against ovarian tumors.
    Lotzová E; Savary CA; Freedman R; Bowen JM
    Comp Immunol Microbiol Infect Dis; 1986; 9(2-3):269-75. PubMed ID: 3491727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphokine-activated killer activity of tumor-associated and peripheral blood lymphocytes isolated from patients with ascites ovarian tumors.
    Allavena P; Zanaboni F; Rossini S; Merendino A; Bonazzi C; Vassena L; Mangioni C; Mantovani A
    J Natl Cancer Inst; 1986 Oct; 77(4):863-8. PubMed ID: 3489856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of natural killer cell activation: implementation for the control of tumor metastasis.
    Hanna N
    Nat Immun Cell Growth Regul; 1983-1984; 3(1):22-33. PubMed ID: 6235447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial activity of various immunomodulators: independence from normal levels of circulating monocytes and natural killer cells.
    Morahan PS; Dempsey WL; Volkman A; Connor J
    Infect Immun; 1986 Jan; 51(1):87-93. PubMed ID: 2416693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rejection of murine ovarian cancer following treatment with regional immunotherapy: correlations with a neutrophil-mediated activation of cytostatic macrophages.
    Lichtenstein A
    Cell Immunol; 1985 Sep; 94(2):521-35. PubMed ID: 4028167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of conditions allowing Corynebacterium parvum to cause either augmentation or inhibition of natural killer cell activity against tumor cells in mice.
    Ojo E; Haller O; Kimura A; Wigzell H
    Int J Cancer; 1978 Apr; 21(4):444-52. PubMed ID: 149772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumoricidal and immunoregulatory activity of macrophages from human ovarian carcinomas.
    Peri G; Biondi A; Bottazzi B; Polentarutti N; Bordignon C; Mantovani A
    Adv Exp Med Biol; 1982; 155():737-44. PubMed ID: 7158509
    [No Abstract]   [Full Text] [Related]  

  • 20. Intraperitoneal administration of interferon beta in ovarian cancer patients.
    Rambaldi A; Introna M; Colotta F; Landolfo S; Colombo N; Mangioni C; Mantovani A
    Cancer; 1985 Jul; 56(2):294-301. PubMed ID: 2408731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.